Mechanisms of human kidney stone formation

Urolithiasis

Volumn 43, Issue 1, 2014, Pages 19-32

  Evan, Andrew P ^a   Worcester, Elaine M ^b   Coe, Fredric L ^b   Williams, James ^a   Lingeman, James E ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c METHODIST HOSPITAL   (United States)

Author keywords

Bellini duct plugs; Histopathology; Interstitial plaque; Renal physiology; Stone forming phenotypes; Surgical anatomy

Indexed keywords

ANIMAL MODEL; BELLINI DUCT; CLINICAL FEATURE; HUMAN; IN VITRO STUDY; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY PAPILLA; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STONE FORMATION; KIDNEY CALCULI; PATHOLOGY;

HUMANS; KIDNEY CALCULI;

EID: 84922079211     PISSN: 21947228     EISSN: 21947236     Source Type: Journal    
DOI: 10.1007/s00240-014-0701-0     Document Type: Review

References (70)

1. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Patterson RF, Kuo RL, Grynpas M (2003) Randall Plaque of patients with nephrolithisis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616
2. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591
3. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Philips CL, Worcester EM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227–2235
4. Evan A, Lingeman J, Coe FL, Worcester E (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313–1318
5. Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester EM (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795–801
6. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec 291:325–334
7. Evan AP, Lingeman JE, Coe FL, Miller N, Bledsoe S, Sommer A, Williams J, Shao Y, Worcester E (2008) Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223–229
8. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM (2009) Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76:1081–1088
9. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Phillips CL, Coe FL (2010) Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78:310–317
10. Worcester EM, Evan AE, Coe FL, Lingeman JE, Krambeck A, Sommer A, Philips CL, Milliner D (2013) A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type 1. AJP 305:F1574–F1584
11. Evan AP, Lingeman J., Worcester EM, Sommer AJ, Phillips CL, Williams JC, Coe FL. (2013) Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (In press)
12. Miller NL, Gillen DL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE (2009) A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 103:966–971
13. Coe FL, Evan AP, Lingeman JE, Worcester EM (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239–247
14. Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147–160
15. Linnes MP, Krambeck AE, Cornell L, Williams JC, Korinek M, Bergstrald EJ, Rule AD, McCollough CM, Vritiska TJ, Lieske JC (2013) Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intra-renal calcifications. Kidney Int 84:818–825
16. Khan SR, Finlayson B, Hackett RL (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urol 23:194–199
17. Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol 158:2062–2064
18. Verkoelen CF, Verhulst A (2007) Proposed mechanisms in renal tubular crystal retention. Kidney Int 72:13–18
19. Vermeulen CW, Lyon ES (1968) Mechanisms of genesis and growth of calculi. Am J Med 45:684–692
20. Finlayson B, Reid F (1978) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442–448
21. Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854
22. Randall A (1937) The origin and growth of renal calculi. Ann Surg 105:1009–1027
23. Miller NL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa S, Lingeman JE (2010) In idiopathic calcium oxalate stone formers, unattached stones show evidence of having originated as attached stones on Randall’s plaque: a micro CT study. BJU Int 105:242–245 PMC2807918
24. Henneman PH, Benedict PH, Fotbes A, Dudley R (1958) Idiopathic hypercalcuria. N Engl J Med 259:802–907
25. Coe FL, Evan E, Worcester E (2005) Kidney stone disease. J Clin Invest 115:2598–2608
26. Evan AP (2007) Histopathology predicts the mechanism of stone formation. In: Evan AP, Lingeman JE, Williams JC (eds) Renal Stone Disease: Proceedings of the First International Urolithiasis Research Symposium. American Institute of Physics, Melville, NY, pp 15–25
27. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323
28. Gokhale JA, McKee MD, Khan SR (1996) Immunocytochemical localization of Tamm-Horsfall protein in the kidneys of normal and nephrolithic rats. Urol Res 24:201–209
29. Asplin JR, Mandel NS, Coe FL (1996) Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613
30. Jamison RL, Frey NR, Lacy FB (1974) Calcium reabsorption in the thin loop of Henle. Am J Physiol 227:745–751
31. Bergsland KJ, Worcester EM, Coe FL (2013) Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol 305:F853–F860
32. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL (2008) Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol 295:F1286–F1294
33. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL (2007) Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol 292:F66–F75
34. Brannan PG, Morawski S, Pak CY, Fordtran JS (1979) Selective jejunal hyperabsorption of calcium in absorptive hypercalciuria. Am J Med 66:425–428
35. Broadus AE, Dominguez M, Batter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751–760
36. Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Intl 72:1503–1511
37. Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Intl 68:145–154
38. Khan SR, Rodriguez DE, Gower LB, Monga M (2012) Association of Randall plaque with collagen fibers and membrane vesicles. J Urol 187:1094–1100
39. Bost F, arra-Mehrpour M, Martin JP (1998) Inter-alpha-trypsin inhibitor proteoglycan family—a group of proteins binding and stabilizing the extracellular matrix. Eur J Biochem 252:339–346
40. Merchant M, Cummins T, Wilkey D, Salyer S, Powell D, Klein J, Lederer ED (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol 295:F1254–F1258
41. Canales B, Anderson l, Higgins L, Slaton J, Roberts K, Liu N, Monga M (2008) Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J Endourol 22:1161–1167
42. Mushtaq S, Siddiqui A, Naqvi Z, Rattani A, Talati J, Palmberg C, Shafqat J (2007) Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acata 384:41–47
43. Kaneko K, Yamanobe T, Nakagomi K, Mawatari K, Onoda M, Fujimori S (2004) Detection of protein Z in a renal calculus composed of calcium oxalate monohydrate with the use of liquid chromatography-mass spectrometry/mass spectrometry following-two dimensional polyacrylamide gel electrophoresis separation. Anal Biochem 324:191–196
44. Kaneko K, Yamanobe T, Onoda M, Mawatari K, Nakagomi K, Fujimori S (2005) Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS. Urol Res 33:415–421
45. Kaneko K, Kobayashi R, Yasuda M, Izumi Y, Yamanobe T, Shimizu T (2012) Comparison of matrix proteins in different types of urinary stone by proteomic analysis using liquid chromatography-tandem mass spectrometry. Int J Urol 19:765–772
46. Jou YC, Fang CY, Chen SY, Chen FH, Cheng MC, Shen CH, Liao LW, Tsai YS (2012) Proteomic study of renal uric acid stone. Urology 80:260–266
47. Williams JC Jr, McAteer JA, Evan AP, Lingeman JE (2010) Micro-computed tomography for analysis of urinary calculi. Urol Res 38:477–484
48. Asplin JR, Parks JH, Coe FL (1997) Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Intl 52:1602–1608
49. Parks JH, Coward M, Coe FL (1997) Corresondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Intl 51:894–900
50. Boyce WH (1968) Organic matrix of human urinary concretions. Am J Med 45:673–683
51. Boyce W, Garvey FK (1956) The amount and nature of organic matrix in urinary calculi: a review. J Urol 76:213–227
52. Willis LR, Evan AP, Connors BA, Blomgren PM, Fineberg N, Lingeman JE (1999) Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol 10:1753–1762
53. Evan A, Willis L, Lingeman J, McAteer J (1998) Renal trauma and the risk of long-term complications in shock wave lithotripsy. Nephron 78:1–8
54. McAteer JA, Evan AP (2008) The acute and long-term adverse effects of shock wave lithotripsy. Sem Nephrol 28:200–213
55. Vervaet BA, Verhulst A, Dauwe SE, De Broe ME, D’Haese PC (2009) An active renal crystal clearance mechanism in rat and man. Kidney Intl 75:41–51
56. Jennette JC, Falk RJ (2005) Glomerular clinicopathologic syndrome. In: A Greeburg, AK CHenug (eds.), Primer in kidney disease. Saunders, Philadelphia, pp. 150–169
57. Khan SR, Hackett RL (1985) Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scan Electron Microsc 2:759–774
58. Khan SR, Shevock PN, Rl Hackett (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226–230
59. Khan SR (2010) Nephrocalcinosis in animal models with and without stones. Urol Res 38:429–438
60. Vervaet BA, Verhulst A, D’Haese PC, De Broe ME (2009) Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant 24:2030–2035
61. Jiang Z, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Notttoli TP, Binder HJ, Aronson PS (2006) Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38:474–478
62. Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL (2010) Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res 38:439–452
63. Liu Y, Mo L, Goldfarb DS, Evan AP, Liang F, Khan SR, Lieske JC, Wu XR (2010) Progressive renal papillary calcification and ureteral stone formtion in mice deficent for Tamm-Horsfall protein. Am J Physiol 299:F469–F478
64. Verkoelen CF, van der Boom BG, Houtsmuller AB, Schroder FH, Romijn JC (1998) Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274:F958–F965
65. Verkoelen CF, van der Boom BG, Kok DJ, Houtsmuller AB, Viser P, Schroder FH, Romijn JC (1999) Cell type-specific acquired protection from crystal adherence by renal tubule cells in culture. Kidney Int 55:1426–1433
66. Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS (2001) Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59:637–644
67. Khan SR, Thamilselvan S (2000) Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4:305–312
68. Verhulst A, Asselman M, Persy VP, Schepers MS, Helbert MF, Verkoelen CF, De Broe ME (2003) Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding- into a nonadherent epithelium. J Am Soc Nephrol 14:107–115
69. Verhulst A, Asselman M, De Naeyer S, Vervaet BA, Mengel M, Gwinnwr W, D’Haese PC, Verkoelen CF, Be Broe ME (2005) Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 68:1643–1647
70. Parks JH, Coe FL (2009) Evidence for durable kidney stone prevention over several decades. BJU Int 103:1238–1246